Developer docs
API playgroundTry for free, no card

Search company profiles

Adare Biome

Full company profile

uuid002b2ry

Namestring
Adare Biome
Websiteurl
adarebiome.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Adare Biome is a Paris-based B2B ingredient supplier that develops and commercializes microbiome-derived postbiotic solutions for human and animal health. The company operates a portfolio centered on the Humiome® Postbiotics line — most notably Humiome® Post LB, which combines proprietary Lactobacillus strains, metabolites, and fermented culture medium produced through a proprietary fermentation process that enriches, concentrates, and heat-stabilizes the microorganisms. This process is the technical core of the offering: it converts live microbial cultures into inanimate, shelf-stable postbiotic ingredients that overcome the standardization, transport, and storage limitations of conventional probiotics, and that can be deployed across digestive health, metabolic health, heart health, brain health, and immunity applications.

The business model is a direct-to-manufacturer ingredient sale with global reach, supported by expert consultation services. Primary customers are nutritional supplement manufacturers developing digestive and overall-wellbeing products; a secondary segment comprises early life nutrition companies formulating infant nutrition with biotic supplementation. Go-to-market relies on a combination of direct enterprise sales, industry trade shows, and a content-led demand generation engine (Talking Nutrition blog, whitepapers, webinars) that targets health nutrition professionals and manufacturer R&D teams. Pricing is not publicly disclosed, consistent with a negotiated B2B ingredient supply model.

Adare Biome's commercial identity is now nested within dsm-firmenich's Health, Nutrition & Care business — the Humiome® Postbiotics portfolio is hosted on dsm-firmenich.com corporate infrastructure and the dsm-firmenich logo system — giving the franchise access to a multinational ingredient sales and manufacturing footprint that a standalone postbiotic player would not have. The company positions itself as a pioneer in the postbiotic category, the most recently defined tier of biotics, and is investing in category-creation content and education to expand the addressable market beyond the roughly 48% of digestive-health supplement users who currently use postbiotics.

Short descriptiontext

Adare Biome is a Paris-based B2B ingredient supplier developing microbiome-derived postbiotic solutions (Humiome® portfolio) for human and animal health. It sells proprietary heat-stabilized Lactobacillus-based ingredients to nutritional supplement manufacturers and early life nutrition companies globally via dsm-firmenich.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
postbiotic ingredients, microbiome solutions, biotic formulations, gut health ingredients, probiotic alternatives
Industry4 codes
1Microbiome-Derived Metabolite Therapeutics (postbiotics)
CodeHLAAAFABPrimaryYes
2Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases)
CodeAFAJAJAEPrimaryNo
3Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI)
CodeHLAMAHAHPrimaryNo
4Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials)
CodeAFADALAEPrimaryNo
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Postbiotic Ingredients
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Adare Biome develops and supplies postbiotic ingredients for human and animal health applications through its Humiome® Postbiotics portfolio. The ingredients combine inanimate microorganisms (e.g., heat-treated Lactobacillus strains) with their metabolites and fermented culture medium, and are sold to nutritional supplement, early-life nutrition, and food/beverage manufacturers for digestive, metabolic, heart, brain, and immune health end-products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The product offering centers on the Humiome® Postbiotics portfolio, which represents dsm-firmenich's postbiotic solution line for the biotics market. The core product Humiome® Post LB consists of proprietary Lactobacillus strains combined with metabolites and fermented culture medium. These postbiotic ingredients are positioned for digestive health, metabolic health, heart health, brain health, and immunity applications. The portfolio is complemented by the Health from the Gut solution area that leverages the Humiome® ingredients to support gut microbiome health through selective support of keystone species, bacterial metabolism, and intestinal barrier strengthening.

Product and service2 records
1Humiome® Postbiotics
CategoryPostbiotic ingredients
Description

A portfolio of postbiotic ingredients combining inanimate microorganisms (such as heat-treated Lactobacillus strains), their metabolites, and fermented culture medium, provided as standardized, stable microbiome actives for nutritional supplement and food/beverage manufacturers.

2Humiome® Post LB
CategoryPostbiotic ingredients
Description

A postbiotic ingredient based on the Lactobacillus LB strain combined with its metabolites, positioned for digestive health applications within Early Life Nutrition (Infant/Toddler) and Dietary Supplements.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global fermentation specialist (yeasts, probiotics, postbiotics) serving nutrition and human health markets. Closely comparable fermentation-driven biotic ingredient supplier to Adare Biome.

TypeDirect peer
Description

Specialist probiotic and yeast-based ingredient supplier for human health and nutrition markets. Closest direct comparable to Adare Biome in B2B probiotic/postbiotic ingredient supply.

TypeDirect peer
Description

Specialist probiotic ingredient supplier focused on Lactobacillus and Bifidobacterium strains for digestive, immune, and metabolic health. Comparable ingredient supplier model and therapeutic positioning.

TypeBroad incumbent
Description

Global probiotic and lactic acid bacteria specialist with B2B licensing and ingredient supply activity alongside its branded products. Operates in the same Lactobacillus-based biotic ingredient space as Adare Biome.

TypeDirect peer
Description

Swedish probiotic strain and finished product company selling Lactobacillus-based ingredients and supplements. Overlaps with Adare Biome's Lactobacillus-based postbiotic offering for digestive and immune health.

TypeBroad incumbent
Description

Major taste and nutrition ingredients group (including Ganeden probiotics) serving supplement and functional food manufacturers worldwide. Competes in the biotics/B2B ingredient space Adare Biome targets.

TypeBroad incumbent
Description

Global microbial and fermentation ingredient powerhouse supplying probiotic and biotic cultures to food, supplement, and infant nutrition manufacturers. Directly comparable B2B ingredient supplier model and customer base to Adare Biome.

8AB Biotics (AB Biotics Human & Animal Health)
TypeDirect peer
Description

Probiotic ingredient supplier with proprietary strains for human and animal health. Comparable niche biotic supplier business model and customer segments to Adare Biome.

TypeBroad incumbent
Description

Global nutrition ingredients major with a growing postbiotic and probiotic portfolio serving supplement and food manufacturers. Competes with Adare Biome for the same manufacturer customers at scale.

TypeBroad incumbent
Description

Large ingredients and biosciences group with a microbial cultures and biotics portfolio serving nutrition customers. Broad incumbent competing with Adare Biome for B2B supplement and functional food customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Adare Biome

Postbiotic Ingredientsadarebiome.com

Adare Biome is a Paris-based B2B ingredient supplier developing microbiome-derived postbiotic solutions (Humiome® portfolio) for human and animal health. It sells proprietary heat-stabilized Lactobacillus-based ingredients to nutritional supplement manufacturers and early life nutrition companies globally via dsm-firmenich.

What Adare Biome does

Adare Biome is a Paris-based B2B ingredient supplier that develops and commercializes microbiome-derived postbiotic solutions for human and animal health. The company operates a portfolio centered on the Humiome® Postbiotics line — most notably Humiome® Post LB, which combines proprietary Lactobacillus strains, metabolites, and fermented culture medium produced through a proprietary fermentation process that enriches, concentrates, and heat-stabilizes the microorganisms. This process is the technical core of the offering: it converts live microbial cultures into inanimate, shelf-stable postbiotic ingredients that overcome the standardization, transport, and storage limitations of conventional probiotics, and that can be deployed across digestive health, metabolic health, heart health, brain health, and immunity applications.

The business model is a direct-to-manufacturer ingredient sale with global reach, supported by expert consultation services. Primary customers are nutritional supplement manufacturers developing digestive and overall-wellbeing products; a secondary segment comprises early life nutrition companies formulating infant nutrition with biotic supplementation. Go-to-market relies on a combination of direct enterprise sales, industry trade shows, and a content-led demand generation engine (Talking Nutrition blog, whitepapers, webinars) that targets health nutrition professionals and manufacturer R&D teams. Pricing is not publicly disclosed, consistent with a negotiated B2B ingredient supply model.

Adare Biome's commercial identity is now nested within dsm-firmenich's Health, Nutrition & Care business — the Humiome® Postbiotics portfolio is hosted on dsm-firmenich.com corporate infrastructure and the dsm-firmenich logo system — giving the franchise access to a multinational ingredient sales and manufacturing footprint that a standalone postbiotic player would not have. The company positions itself as a pioneer in the postbiotic category, the most recently defined tier of biotics, and is investing in category-creation content and education to expand the addressable market beyond the roughly 48% of digestive-health supplement users who currently use postbiotics.

Adare Biome firmographics

Firmographics
Name
Adare Biome
Website
https://adarebiome.com
Company type
Private
Operating status
Operating
Headcount range
251–500 employees
Short description
Adare Biome is a Paris-based B2B ingredient supplier developing microbiome-derived postbiotic solutions (Humiome® portfolio) for human and animal health. It sells proprietary heat-stabilized Lactobacillus-based ingredients to nutritional supplement manufacturers and early life nutrition companies globally via dsm-firmenich.
Ownership category
akta.pro rank

Adare Biome industry classification

Industry
Product category
Postbiotic Ingredients
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Microbiome-Derived Metabolite Therapeutics (postbiotics) (HLAAAFAB)
akta.pro secondary industries
Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases) (AFAJAJAE), Nutraceuticals & Functional Ingredients for Animal Diets (Probiotics, Omega-3, Joint, GI) (HLAMAHAH), Probiotics, Prebiotics & Postbiotics (Direct-Fed Microbials) (AFADALAE)

Keywords

  • Postbiotic ingredients
  • Microbiome solutions
  • Biotic formulations
  • Gut health ingredients
  • Probiotic alternatives

Where Adare Biome is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Markets served

Adare Biome business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Adare Biome product offering

Product offering

Core offering

Adare Biome develops and supplies postbiotic ingredients for human and animal health applications through its Humiome® Postbiotics portfolio. The ingredients combine inanimate microorganisms (e.g., heat-treated Lactobacillus strains) with their metabolites and fermented culture medium, and are sold to nutritional supplement, early-life nutrition, and food/beverage manufacturers for digestive, metabolic, heart, brain, and immune health end-products.

Product overview

The product offering centers on the Humiome® Postbiotics portfolio, which represents dsm-firmenich's postbiotic solution line for the biotics market. The core product Humiome® Post LB consists of proprietary Lactobacillus strains combined with metabolites and fermented culture medium. These postbiotic ingredients are positioned for digestive health, metabolic health, heart health, brain health, and immunity applications. The portfolio is complemented by the Health from the Gut solution area that leverages the Humiome® ingredients to support gut microbiome health through selective support of keystone species, bacterial metabolism, and intestinal barrier strengthening.

Differentiator

Problem solved

Functional benefit

Products and services

  • Humiome® Postbiotics A portfolio of postbiotic ingredients combining inanimate microorganisms (such as heat-treated Lactobacillus strains), their metabolites, and fermented culture medium, provided as standardized, stable microbiome actives for nutritional supplement and food/beverage manufacturers.
  • Humiome® Post LB A postbiotic ingredient based on the Lactobacillus LB strain combined with its metabolites, positioned for digestive health applications within Early Life Nutrition (Infant/Toddler) and Dietary Supplements.

Companies that use Adare Biome

Customer profile

Segments2 records

Ideal customer profiles1 record

Adare Biome technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Adare Biome partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Adare Biome competitors and assessment

Company assessment

Broad incumbents

  • Lesaffre (Gnosis by Lesaffre / yeasts & biotics): Global fermentation specialist (yeasts, probiotics, postbiotics) serving nutrition and human health markets. Closely comparable fermentation-driven biotic ingredient supplier to Adare Biome.
  • Yakult Honsha (ingredient and probiotic business): Global probiotic and lactic acid bacteria specialist with B2B licensing and ingredient supply activity alongside its branded products. Operates in the same Lactobacillus-based biotic ingredient space as Adare Biome.
  • Kerry Group: Major taste and nutrition ingredients group (including Ganeden probiotics) serving supplement and functional food manufacturers worldwide. Competes in the biotics/B2B ingredient space Adare Biome targets.
  • Chr. Hansen (now Novonesis): Global microbial and fermentation ingredient powerhouse supplying probiotic and biotic cultures to food, supplement, and infant nutrition manufacturers. Directly comparable B2B ingredient supplier model and customer base to Adare Biome.
  • ADM (Health & Wellness / Biotics): Global nutrition ingredients major with a growing postbiotic and probiotic portfolio serving supplement and food manufacturers. Competes with Adare Biome for the same manufacturer customers at scale.
  • International Flavors & Fragrances (IFF / Danisco Health & Biosciences): Large ingredients and biosciences group with a microbial cultures and biotics portfolio serving nutrition customers. Broad incumbent competing with Adare Biome for B2B supplement and functional food customers.

Direct peers

  • Lallemand Health Solutions: Specialist probiotic and yeast-based ingredient supplier for human health and nutrition markets. Closest direct comparable to Adare Biome in B2B probiotic/postbiotic ingredient supply.
  • Probi: Specialist probiotic ingredient supplier focused on Lactobacillus and Bifidobacterium strains for digestive, immune, and metabolic health. Comparable ingredient supplier model and therapeutic positioning.
  • BioGaia: Swedish probiotic strain and finished product company selling Lactobacillus-based ingredients and supplements. Overlaps with Adare Biome's Lactobacillus-based postbiotic offering for digestive and immune health.
  • AB Biotics (AB Biotics Human & Animal Health): Probiotic ingredient supplier with proprietary strains for human and animal health. Comparable niche biotic supplier business model and customer segments to Adare Biome.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Adare Biome social profiles

Digital presence

Adare Biome financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Adare Biome leadership team

Management profile

Number of profiles

Adare Biome funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Adare Biome M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adare Biome

What does Adare Biome do?

Adare Biome develops and supplies postbiotic ingredients for human and animal health applications through its Humiome® Postbiotics portfolio. The ingredients combine inanimate microorganisms (e.g., heat-treated Lactobacillus strains) with their metabolites and fermented culture medium, and are sold to nutritional supplement, early-life nutrition, and food/beverage manufacturers for digestive, metabolic, heart, brain, and immune health end-products.

When was Adare Biome founded?

Adare Biome was founded in -1. It employs 251 to 500 people.

Where is Adare Biome based?

Adare Biome is headquartered in Paris, France, in the Europe region.

Who are Adare Biome's main competitors?

Broad incumbents on record are Lesaffre (Gnosis by Lesaffre / yeasts & biotics), Yakult Honsha (ingredient and probiotic business), Kerry Group, Chr. Hansen (now Novonesis), ADM (Health & Wellness / Biotics) and International Flavors & Fragrances (IFF / Danisco Health & Biosciences). Direct peers are Lallemand Health Solutions, Probi, BioGaia and AB Biotics (AB Biotics Human & Animal Health).

Does Adare Biome have an API?

No public API is recorded for Adare Biome.

What industry is Adare Biome in?

Adare Biome's product category is Postbiotic Ingredients. Its primary akta.pro industry code is HLAAAFAB, Microbiome-Derived Metabolite Therapeutics (postbiotics), with a secondary code of AFAJAJAE, Probiotics (Human & Animal Strains, Spore-Formers, Synbiotic Bases). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNutraceutical Ingredients Market worth $161.53 billion by 2031- Exclusive Report by MarketsandMarkets™The global nutraceutical ingredients market is projected to grow from $108.33 billion in 2026 to $161.53 billion by 2031, a CAGR of 7.3%. Asia Pacific is expected to be the largest and fastest-growing region, with human nutrition and functional proteins holding the largest shares.PR NewswireNutraceutical Ingredients Market worth $161.53 billion by 2031- Exclusive Report by MarketsandMarkets™The global nutraceutical ingredients market is projected to grow from $108.33 billion in 2026 to $161.53 billion by 2031, a CAGR of 7.3%. Asia Pacific is expected to be the largest and fastest-growing region, with human nutrition and functional proteins holding the largest shares.Dsm Firmenichdsm-firmenich completes acquisition of postbiotics pioneer Adare Biomedsm-firmenich has completed its acquisition of postbiotics pioneer Adare Biome for an enterprise value of €275 million, positioning itself as a leader in the growing microbiome management market. The deal enables dsm-firmenich to extend Adare Biome's products, including the OTC supplement Lactéol®, through its global distribution network and i-Health B2C unit, while also expanding into animal health. Adare Biome brings over a century of pioneering science and markets its products in nearly 40 countries.PR Newswiredsm-firmenich completes acquisition of postbiotics pioneer Adare Biomedsm-firmenich has completed its acquisition of Adare Biome, a pioneer in postbiotics development and manufacturing, for an enterprise value of €275 million. The transaction closes on terms representing an estimated 2023 EV/EBITDA multiple of 18x.AdarepharmasolutionsAdare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenichAdare Pharma Solutions completed the divestiture of its Adare Biome business unit to dsm-firmenich for an enterprise value of €275 million. The acquisition positions dsm-firmenich as a leader in the microbiome management market, expanding its capabilities in human nutrition and animal health through postbiotic technologies.NewswireAdare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenichAdare Pharma Solutions has completed the divestiture of its Adare Biome business unit to dsm-firmenich for an enterprise value of €275 million. This transaction allows Adare to focus resources on its core CDMO business while enabling dsm-firmenich to expand its leadership in the microbiome management market for human and animal health.PR NewswireAdare Pharma Solutions gibt Veräußerung des Postbiotics-Pioniers, Adare Biome, an dsm-firmenich bekanntAdare Pharma Solutions has completed the divestment of its business unit Adare Biome, a pioneer in postbiotics development and manufacturing, to dsm-firmenich for an enterprise value of 275 million EUR at an estimated 18x EV/EBITDA multiple for 2023. Dsm-firmenich intends to expand Adare Biome's Lactéol postbiotic supplement through its B2C unit i-Health and develop B2B postbiotic ingredients for supplements, early-life nutrition, medical nutrition, and pet microbiome management. The transaction will provide Adare Pharma Solutions with additional resources to strengthen its CDMO core business serving the pharmaceutical industry.PR NewswireAdare Pharma Solutions annonce la cession de Adare Biome, pionnier des postbiotiques, à dsm-firmenichAdare Pharma Solutions has completed the sale of its Adare Biome business unit to dsm-firmenich for an enterprise value of 275 million euros, representing an estimated 2023 EBITDA multiple of 18 times. dsm-firmenich gains Adare Biome's postbiotic portfolio including the Lactéol® over-the-counter supplement and B2B postbiotic ingredients, positioning the company as a leader in the expanding pet microbiome management market. The transaction provides Adare Pharma Solutions with additional resources to strengthen its core contract manufacturing organization (CMO) business serving the pharmaceutical industry.PR NewswireAdare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenichAdare Pharma Solutions completed the divestiture of its Adare Biome business unit to dsm-firmenich for an enterprise value of €275 million at an estimated 2023 EV/EBITDA multiple of 18x. Adare Biome is a pioneer in postbiotics development and manufacturing, best known for its over-the-counter supplement Lactéol. dsm-firmenich plans to expand Adare Biome's postbiotic products across dietary supplements, early-life nutrition, medical nutrition, and animal health markets through its global infrastructure.PR NewswireAdare Pharma Solutions anuncia la venta del pionero de los postbióticos Adare Biome a dsm-firmenichAdare Pharma Solutions completed the sale of its business unit Adare Biome, a pioneer in postbiotic development and manufacturing, to dsm-firmenich for an enterprise value of 275 million euros. The transaction carries an estimated EV/EBITDA multiple of approximately 18x for 2023, and dsm-firmenich plans to expand Adare Biome's postbiotic products including the Lactéol® over-the-counter supplement through its i-Health B2C unit. The acquisition positions dsm-firmenich as a leader in the growing pet microbiome management market and broadens its reach across dietary supplements, early-life nutrition, medical nutrition, and animal health.